Libra Therapeutics

Libra Therapeutics

Libra Therapeutics

Libra Therapeutics is focused on developing novel diseasemodifying therapeutics that can restore the cellularbalance disrupted in neurodegenerative diseases.
Type
B2b
Founded
2019
Raised
$29M
Follow us
Alexa global traffic share
Latest funding
$29,000,000
Venture capital (Series A) - 2020
Dolby Family Ventures Epidarex Capital Sante Ventures +3
Team Size
1–10
Employees
$29,000,000 Venture capital (Series A)
FinSMEs

Libra Therapeutics Raises $29M in Series A Funding